(2026) -
Chronological (580 items)
(All links open in new tab)
| Apr 24, 2026 |
What Happens When Cannabis Magazines are Too Scandalous for Dispensaries?
Fat Nugs Magazine’s Kids and Cannabis issue tackled a tough but necessary conversation. A partner dispensary refused to carry it. What does that say about the industry’s willingness to advance the cannabis conversation? |
|---|---|
| Apr 24, 2026 |
Canadian Cannabis Sales Continued to Advance in February
Statistics Canada released February retail sales for the country, with cannabis sales decreasing from the January levels, down 7.9% to C$440.5 million from the prior month. The sequential decrease was up 2.0% on a per-day basis more due to the fewer days than in the prior month. January, originally reported at C$466.1 million, was revised higher to C$478.2 million. The sales in February were up 7.9% from a year ago, down from the level last month at 9.4% and in May at 8.3% and 7.5% in June but better than the prior lowest annual growth rate since legalization commenced of -0.9% in September 2024 due to the BC strike. In 2024, total sales increased 4.5% to C$5.39 billion, and they were up 4.1% in 2025 to C$5.62 billion. So far in 2026, sales are up 8.6%. |
| Apr 24, 2026 |
What to Know About Trump’s Reclassification of Medical Marijuana
On April 23, acting U.S. attorney general Todd Blanche signed an order changing the federal classification of medical marijuana. The move, which came at the behest of President Donald Trump and will make the substance a Schedule 3 drug, will bring enormous tax benefits to medical marijuana producers in the 40 states where medical use is legal and may speed research into its effects, experts say. But it does not legalize marijuana at the federal level, nor does it change the status of marijuana grown for recreational use. Here’s what you need to know. |
| Apr 24, 2026 |
Reclassifying marijuana as a less dangerous drug might only be the first step for Trump
U.S. President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some barriers to researching cannabis and could even allow the export of marijuana to other countries. But that might only be Trump’s first step. A new administrative hearing slated for the end of June could result in the reclassification of marijuana more broadly, granting tax and other benefits to state-licensed recreational markets, too. |
| Apr 23, 2026 |
Cannabis Use Associated With Lower Likelihood of Metabolic Disorders, Including Hypertension, Type 2 Diabetes, and Obesity
Hangzhou, China: Those with a history of cannabis use possess a lower risk of suffering from metabolic disorders – including hypertension, type 2 diabetes, and obesity, according to data published in the journal Nutrition, Metabolism & Cardiovascular Diseases. Chinese researchers assessed the relationship between cannabis use and metabolic syndromes in a nationally representative sample of 91,000 adults. |
| Apr 23, 2026 |
Trump Pushes Congress To Keep Full-Spectrum CBD Legal While Restricting Hemp Products That Pose ‘Health Risks’
President Donald Trump is urging congressional lawmakers to take action to amend a law that threatens to federally recriminalize hemp-derived full-spectrum CBD products in November. |
| Apr 23, 2026 |
Cannabis Stocks Lose Buzz Despite This Landmark Decision
Cannabis stocks rose Thursday after the Trump administration, in a landmark decision, reclassified marijuana as a less-dangerous drug. But early stock gains faded. Marijuana now goes from being classified among the most dangerous drugs to Schedule III, a federal designation for drugs with a moderate to low potential for dependence and abuse. |
| Apr 23, 2026 |
Market Outlook: U.S. cannabis reclassification drives stock surge
Marijuana stocks surged after the U.S. Department of Justice reclassified cannabis to a lower-risk category, easing restrictions in a major policy shift. |
| Apr 23, 2026 |
Trump administration eases rules on some marijuana categories. Here's what to know
The Trump administration is easing rules on medical marijuana, moving it out of the restrictive Schedule I and into Schedule III — a category shared by drugs such as Tylenol with codeine and anabolic steroids. |
| Apr 23, 2026 |
Marijuana Reclassification Explained: What the Trump Administration’s Schedule 3 Move Actually Means
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer. |
| Apr 22, 2026 |
Canada’s cannabis export dominance remains despite global price compression, rising standards
The global medical cannabis market is growing quickly but inconsistently, with tightening regulatory environments and a competitive supply chain where margins are universally compressing, according to the newest market report from the Global Cannabis Exchange. |
| Apr 22, 2026 |
US set to move to reclassify marijuana as early as Wednesday, Axios reports
WASHINGTON, April 22 (Reuters) - The United States administration is expected to move to ?reclassify marijuana as soon as Wednesday, Axios reported, ?citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher. The decision to reclassify marijuana would represent one of the ?most significant federal changes to marijuana policy in ?decades, removing barriers to researching the drug's potential ?use cases. |
| Apr 22, 2026 |
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics. It comes just days after one of the country’s largest and most widely respected polling companies, YouGov, published the results of a representative survey examining the British public’s attitudes towards cannabis. |
| Apr 22, 2026 |
Six Out Of Ten Americans Support Legalizing Marijuana, New Poll Shows
Americans broadly favor legalizing marijuana for recreational or medical purposes, with support across party lines, according to a new poll. The YouGov survey from published on Monday found that 59 percent of U.S. adults want to legalize cannabis—including 75 percent of Democrats, 50 percent of Republicans and 54 percent of independents. |
| Apr 22, 2026 |
Rosin, Raids and Risk: Spain’s New Cannabis Frontier
On a cold night in late January 2025, a home lab in Espinardo (Murcia) ended in tragedy. Two young men were killed when a butane-based cannabis extraction attempt went catastrophically wrong. As the local press later reported, the pair had been attempting to produce highly concentrated hash oil — BHO, short for butane hash oil — by blasting cannabis with flammable gas. The blast leveled the walls, igniting a deadly fire. |
| Apr 22, 2026 |
Victoria Cannabis Buyers Club says about $100,000 in products seized in raid
Provincial authorities raided the Victoria Cannabis Buyers Club on Tuesday, more than three years after the last raid on the unlicensed non-profit dispensary, which sells cannabis products to mostly low-income people with chronic illnesses. Club founder Ted Smith said officers with the province’s Community Safety Unit arrived Tuesday morning shortly after the shop opened and began seizing products. |
| Apr 21, 2026 |
Iowa Gubernatorial Candidate Plans to Legalize Adult-Use Cannabis, Regulate Hemp Products
Iowa’s 2026 governor’s race is now considered a toss-up, and the lone Democratic candidate pulled back the curtain on his plans to legalize adult-use cannabis and regulate cannabinoid hemp products. Rob Sand, who has served as Iowa’s state auditor since 2019 – he was the only Democrat to win a statewide election race in 2022 – released the details of his plan to legalize, tax and regulate adult-use cannabis similar to alcohol on April 20, an international cannabis holiday. |
| Apr 21, 2026 |
Bipartisan Congressional Bill to Let States Have Their Own Hemp THC Rules
A new bipartisan effort in Congress is offering states a way to sidestep an upcoming federal crackdown on hemp-derived THC products, instead of forcing an immediate nationwide ban. The proposal, introduced last week, would let individual states maintain their existing regulatory systems rather than adopt a stricter federal standard scheduled to begin in November. |
| Apr 21, 2026 |
The Extinction of the Real: How Traditional Hashish Vanished While the Modern Market Looked Away
Traditional imported hashish—hand-rubbed Nepali charas, Lebanese blonde, Moroccan temple balls, Afghani black—has effectively vanished from North American markets. This is not a story about enforcement or interdiction. This is a story about market economics and how legalization ironically destroyed demand for the very craft products it claimed to celebrate. |
| Apr 21, 2026 |
Cannabis Industry Council Releases Global Guide for Patients Travelling with Medical Cannabis
The UK’s Cannabis Industry Council (CIC) has published a new comprehensive guide for patients travelling with prescribed medical cannabis in the wake of a series of reported incidents involving both airlines and border control authorities. The guide, Travelling with Medical Cannabis, published today and available free via the CIC’s website, covers domestic UK travel, international country-by-country frameworks across Europe, the Americas, Asia, the Middle East, Africa and Australasia, and includes a practical pre-travel checklist. |